- Home
- AGO vs PTGX Comparison
AGO vs PTGX Comparison
Compare AGO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGO
- PTGX
- Stock Information
- Founded
- AGO 2003
- PTGX 2006
- Country
- AGO Bermuda
- PTGX United States
- Employees
- AGO N/A
- PTGX N/A
- Industry
- AGO Property-Casualty Insurers
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AGO Finance
- PTGX Health Care
- Exchange
- AGO Nasdaq
- PTGX Nasdaq
- Market Cap
- AGO 4.1B
- PTGX 3.3B
- IPO Year
- AGO 2004
- PTGX 2016
- Fundamental
- Price
- AGO $82.25
- PTGX $58.97
- Analyst Decision
- AGO Buy
- PTGX Strong Buy
- Analyst Count
- AGO 2
- PTGX 8
- Target Price
- AGO $98.50
- PTGX $70.13
- AVG Volume (30 Days)
- AGO 353.6K
- PTGX 646.3K
- Earning Date
- AGO 08-07-2025
- PTGX 08-06-2025
- Dividend Yield
- AGO 1.66%
- PTGX N/A
- EPS Growth
- AGO N/A
- PTGX N/A
- EPS
- AGO 9.06
- PTGX 0.80
- Revenue
- AGO $891,000,000.00
- PTGX $209,180,000.00
- Revenue This Year
- AGO N/A
- PTGX N/A
- Revenue Next Year
- AGO N/A
- PTGX $185.11
- P/E Ratio
- AGO $9.04
- PTGX $73.40
- Revenue Growth
- AGO 3.01
- PTGX N/A
- 52 Week Low
- AGO $74.09
- PTGX $33.31
- 52 Week High
- AGO $96.50
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- AGO 48.49
- PTGX 57.69
- Support Level
- AGO $81.08
- PTGX $55.26
- Resistance Level
- AGO $82.40
- PTGX $58.79
- Average True Range (ATR)
- AGO 1.21
- PTGX 2.20
- MACD
- AGO 0.11
- PTGX 0.39
- Stochastic Oscillator
- AGO 81.75
- PTGX 66.84
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.